Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03759717 · ClinicalTrials.gov registry record
Molecular and Cellular Characterization of Skull Base Tumors
A clinical trial of Skull Base Neoplasm and Cellular Pathology, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 1
- Study location
NCT03759717 is a study of Skull Base Neoplasm and Cellular Pathology that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 4,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03759717, a study of Skull Base Neoplasm and Cellular Pathology, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to analyze biological samples and genetic material for basic science research investigating the molecular and cellular characterization of skull base tumors.
Conditions Studied
Interventions
- OTHER Observation
Study Locations (1)
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2018-10-03 |
| Est. Completion | 2028-10-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03759717
The ClinicalTrials.gov registry entry for NCT03759717 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Skull Base Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which Observation is the first listed.
NCT03759717 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03759717 about?
NCT03759717 is a clinical study titled "Molecular and Cellular Characterization of Skull Base Tumors". The purpose of the study is to analyze biological samples and genetic material for basic science research investigating the molecular and cellular characterization of skull base tumors.
What is the current status of trial NCT03759717?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2018-10-03. Estimated completion is 2028-10-03.
What conditions does trial NCT03759717 study?
This clinical trial studies the following conditions: Skull Base Neoplasm, Cellular Pathology.
What interventions are being tested in trial NCT03759717?
The interventions under investigation include: Observation (OTHER).
Who is sponsoring clinical trial NCT03759717?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03759717 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.